Non-monoaminergic systems in schizophrenia

B. N M Van Berckel, J. M. Van Ree, R. S. Kahn

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

In the past, schizophrenic research has focussed on mono-aminergic systems, particularly dopaminergic systems. Less is known about the contribution of non-monoaminergic systems in the pathology of schizophrenia. The significance of non-monoaminergic systems, like excitatory aminoacids, cholecystokinin, σ-receptors and γ-type endorphins, for schizophrenia research are discussed. Several trials have been performed with cholecystokinin and γ-type endorphins. The results of open and single blind experiments with these peptides were promising. However the outcome of the first double-blind, placebo-controlled, studies were less positive. In both cases there are not enough double-blind, placebo-controlled studies available to give a definite judgement about the role of these peptiden in the pathology of schizophrenia. Far less studies have been done with σ-receptors antagonists and excitatory aminoacids. Therefore more trials with σ-receptors antagonists and excitatory aminoacids are needed to establish the role of these systems in the pathology of schizophrenia.

Translated title of the contributionNon-monoaminergic systems in schizophrenia
Original languageDutch
Pages (from-to)762-775
Number of pages14
JournalTijdschrift voor Psychiatrie
Volume36
Issue number10
Publication statusPublished - 1 Jan 1994

Cite this

Van Berckel, B. N. M., Van Ree, J. M., & Kahn, R. S. (1994). NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE. Tijdschrift voor Psychiatrie, 36(10), 762-775.
Van Berckel, B. N M ; Van Ree, J. M. ; Kahn, R. S. / NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE. In: Tijdschrift voor Psychiatrie. 1994 ; Vol. 36, No. 10. pp. 762-775.
@article{a992a26a054244fd83fcdfbd5043c1e9,
title = "NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE",
abstract = "In the past, schizophrenic research has focussed on mono-aminergic systems, particularly dopaminergic systems. Less is known about the contribution of non-monoaminergic systems in the pathology of schizophrenia. The significance of non-monoaminergic systems, like excitatory aminoacids, cholecystokinin, σ-receptors and γ-type endorphins, for schizophrenia research are discussed. Several trials have been performed with cholecystokinin and γ-type endorphins. The results of open and single blind experiments with these peptides were promising. However the outcome of the first double-blind, placebo-controlled, studies were less positive. In both cases there are not enough double-blind, placebo-controlled studies available to give a definite judgement about the role of these peptiden in the pathology of schizophrenia. Far less studies have been done with σ-receptors antagonists and excitatory aminoacids. Therefore more trials with σ-receptors antagonists and excitatory aminoacids are needed to establish the role of these systems in the pathology of schizophrenia.",
author = "{Van Berckel}, {B. N M} and {Van Ree}, {J. M.} and Kahn, {R. S.}",
year = "1994",
month = "1",
day = "1",
language = "Dutch",
volume = "36",
pages = "762--775",
journal = "Tijdschrift voor Psychiatrie",
issn = "0303-7339",
publisher = "Uitgeverij Boom",
number = "10",

}

Van Berckel, BNM, Van Ree, JM & Kahn, RS 1994, 'NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE' Tijdschrift voor Psychiatrie, vol. 36, no. 10, pp. 762-775.

NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE. / Van Berckel, B. N M; Van Ree, J. M.; Kahn, R. S.

In: Tijdschrift voor Psychiatrie, Vol. 36, No. 10, 01.01.1994, p. 762-775.

Research output: Contribution to journalReview articleAcademicpeer-review

TY - JOUR

T1 - NON-MONOAMINERGE SYSTEMEN BIJ SCHIZOFRENIE

AU - Van Berckel, B. N M

AU - Van Ree, J. M.

AU - Kahn, R. S.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - In the past, schizophrenic research has focussed on mono-aminergic systems, particularly dopaminergic systems. Less is known about the contribution of non-monoaminergic systems in the pathology of schizophrenia. The significance of non-monoaminergic systems, like excitatory aminoacids, cholecystokinin, σ-receptors and γ-type endorphins, for schizophrenia research are discussed. Several trials have been performed with cholecystokinin and γ-type endorphins. The results of open and single blind experiments with these peptides were promising. However the outcome of the first double-blind, placebo-controlled, studies were less positive. In both cases there are not enough double-blind, placebo-controlled studies available to give a definite judgement about the role of these peptiden in the pathology of schizophrenia. Far less studies have been done with σ-receptors antagonists and excitatory aminoacids. Therefore more trials with σ-receptors antagonists and excitatory aminoacids are needed to establish the role of these systems in the pathology of schizophrenia.

AB - In the past, schizophrenic research has focussed on mono-aminergic systems, particularly dopaminergic systems. Less is known about the contribution of non-monoaminergic systems in the pathology of schizophrenia. The significance of non-monoaminergic systems, like excitatory aminoacids, cholecystokinin, σ-receptors and γ-type endorphins, for schizophrenia research are discussed. Several trials have been performed with cholecystokinin and γ-type endorphins. The results of open and single blind experiments with these peptides were promising. However the outcome of the first double-blind, placebo-controlled, studies were less positive. In both cases there are not enough double-blind, placebo-controlled studies available to give a definite judgement about the role of these peptiden in the pathology of schizophrenia. Far less studies have been done with σ-receptors antagonists and excitatory aminoacids. Therefore more trials with σ-receptors antagonists and excitatory aminoacids are needed to establish the role of these systems in the pathology of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=0028077807&partnerID=8YFLogxK

M3 - Review article

VL - 36

SP - 762

EP - 775

JO - Tijdschrift voor Psychiatrie

JF - Tijdschrift voor Psychiatrie

SN - 0303-7339

IS - 10

ER -